Content about Vagina

March 26, 2014

Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel. The antibiotic is used for the treatment of bacterial vaginosis, an infection caused by an imbalance in the normal bacteria of vagina.

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel.

The antibiotic is used for the treatment of bacterial vaginosis, an infection caused by an imbalance in the normal bacteria of vagina. It's the most common vaginal infection in women ages 15 years to 44 years. Metronidazole 1.3% provides a single-dose treatment that is packaged in a pre-filled disposable applicator.

August 6, 2013

Actavis has acquired global rights to a drug made by a Spanish company for fungal infections of the vagina, the companies said Tuesday.

PARSIPPANY, N.J. — Actavis has acquired global rights to a drug made by a Spanish company for fungal infections of the vagina, the companies said Tuesday.

Actavis and Palau Pharma announced that Actavis Specialty Brands had acquired right's to albaconazole, an orally administered antifungal for vulvo-vaginal candidiasis, onychomycosis and others. The drug, which Palau discovered, is currently in phase-2 clinical trials, and Actavis foresees a potential U.S. commercial launch of the drug in 2017.

August 5, 2013

A new treatment for bacterial infections of the vagina is now available, the drug's manufacturer said.

ST. LOUIS — A new treatment for bacterial infections of the vagina is now available, the drug's manufacturer said Monday.

K-V Pharmaceutical Co. subsidiary Ther-Rx Corp. announced the availability of Clindesse (clindamycin phosphate), saying wholesalers have ordered and received it and are distributing it to retail pharmacies. The drug is used to treat bacterial vaginosis in women who are not pregnant. BV results from an overgrowth of several bacterial species and is the most common vaginal infection in women of childbearing age.

January 31, 2013

Research has shown that 3-in-4 women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced, citing an independent survey commissioned for Monistat.

TREVOSE, Pa. — Research has shown that three in four women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced Wednesday, citing an independent survey commissioned for Monistat.

November 28, 2012

Regional life sciences association Biocom has introduced a new eco-friendly alternative to sanitary napkins and tampons. Enter FemmyCycle, a product from member FemCap.

SAN DIEGO — Regional life sciences association Biocom has introduced a new eco-friendly alternative to sanitary napkins and tampons. Enter FemmyCycle, a product from member FemCap.

The FemmyCycle was granted clearance by the U.S. Food and Drug Administration on Nov. 16. FemmyCycle creator Alfred Shihata is familiar with developing feminine products. His FDA-approved FemCap is one of the few hormone-free, woman-controlled contraceptive methods available.

May 23, 2012

The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

Perrigo announced the approval of butoconazole nitrate 2% vaginal cream, a generic version of KV Pharmaceutical's Gynazole-1, used to treat vulvovaginal candidiasis, an infection caused by Candida fungus. KV voluntarily discontinued selling the drug in January 2009 due to manufacturing problems.

November 10, 2011

Kimberly-Clark on Wednesday recalled a limited number of a Kotex product distributed to specific stores in the United States.

DALLAS — Kimberly-Clark on Wednesday recalled a limited number of a Kotex product distributed to specific stores in the United States.

June 27, 2011

Feminine hygiene brand Summer's Eve recently launched a video that encourages dialogue about the female anatomy.

LYNCHBURG, Va. — Feminine hygiene brand Summer's Eve recently launched a video that encourages dialogue about the female anatomy.

The brand launched the "That's Vaginal!" video to encourage consumers to move away from euphemisms and from treating the vagina as a taboo topic, Summer's Eve said, adding that the video will be supported with a redesigned website and candid attitude.

September 12, 2010

Lil' Drug Store Products has launched a "brilliant" feminine protection product....

NEW YORK Lil' Drug Store Products has launched a "brilliant" feminine protection product.

New RepHresh Brilliant tampons reduce the pH increase that occurs during a woman's period.

"In healthy women, vaginal pH is typically 3.5 to 4.5 and blood has a pH of 7.4, so during a woman's period, pH is elevated by menstrual fluids. Tampons retain the fluids that cause pH to increase. RepHresh Brilliant is the first tampon clinically shown to reduce the usual pH increase," said Lauren Streicher, assistant clinical professor of obstetrics and gynecology.

March 15, 2010

Kimberly-Clark has launched a new feminine care brand that hopes to redefine the personal care...